Syngene International Ltd

Syngene International Ltd | Sector: Pharmaceuticals | ISIN: INE398R01022

₹ 594.50 (2.69%) icon

31 Mar, 2023, 3:40:33 PM
Open
₹ 578.95
Prev. Close
₹ 578.95
Turnover(lac)
₹ 3,572.56
Day's High
₹ 601.50
Day's Low
₹ 578.05
52 Wk High
₹ 683.00
52 Wk Low
₹ 510.05
Book Value
₹ 89.10
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 23,865.28
P/E
55.36
EPS
10.74
Div. Yield
0.17

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 3/31/2023 3:40:33 PM

    ₹ 594.5 15.55 2.69
  • Open
  • ₹ 578.95
  • Prev. Close
  • ₹ 578.95
  • Turnover(Lac.)
  • ₹ 3,573
  • Day's High
  • ₹ 601.5
  • Day's Low
  • ₹ 578.05
  • 52 Week's High
  • ₹ 683
  • 52 Week's Low
  • ₹ 510.05
  • Book Value
  • ₹ 89.1
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 23,865.28
  • P/E
  • 55.36
  • EPS
  • 10.74
  • Divi. Yield
  • 0.17

Corporate Actions

06 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Jan , 2023

12:00 AM

06 Oct , 2022

12:00 AM

06 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

27 Apr , 2022

12:00 AM

AGM

Announcement date: 27 Apr , 2022

View Details

04 Jul , 2022

12:00 AM

27 Apr , 2022

12:00 AM

Dividend

Dividend amount: 0.5
Announcement date: 27 Apr , 2022

View Details

27 Apr , 2022

12:00 AM

Dividend

Dividend amount: 0.5
Announcement date: 27 Apr , 2022

View Details

05 Apr , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

SHAREHOLDING SNAPSHOT
02 April , 2023 | 07:15 AM

PROMOTER - TOTAL64.86%

Indian: 64.86%

Foreign: 0.0034%

NON-PROMOTER - TOTAL 34.67%

Institutions: 23.90%

Non-Institutions: 10.77%

CUSTODIES - 0.47%

Custodies: 0.47%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Syngene International Ltd News and Update

Article Image
  • 27 March, 2023 |
  • 4:08 PM

The valuation of the company was estimated to be up to $3 billion.

Image not found
  • IIFL News Service |
  • 24 March, 2023 |
  • 4:03 PM
Article Image
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Syngene International Ltd

  • Kiran Mazumdar Shaw

  • Chairperson
  • Catherine Patricia Rosenberg

  • Director
  • Paul Frederick Blackburn

  • Independent Director
  • Vijay Kuchroo

  • Independent Director
  • Jonathan Hunt

  • Managing Director & CEO
  • Vinita Bali

  • Independent Director
  • Priyadarshnini Mahapatra

  • Company Sec. & Compli. Officer
  • Sharmila Karve

  • Independent Director
  • Carl Decicco

  • Director
  • Kush Parmar

  • Independent Director

Summary

Syngene International Limited is an integrated research, development and manufacturing services organization. Headquartered in India, the operations are driven by its highly qualified teams comprising ~5200 scientists and its state-of-the-art facilities, spread over 2 million sq. ft., across three locations in India: Bangalore, Hyderabad and Mangalore. The Company operate in 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated R&D Centres.The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited. The Companys health-related services extend across all major therapeutic areas and modalities. It provides end-to-end services within the Contract Research Organization (CRO) and a growing range of services within the Contract Development and Manufacturing Organization (CDMO). The primary target market for these services is the pharmaceutical and biotechnology (biotech) sectors. The same scientific capabilities that serve human health also serve nutrition, animal health, consumer goods, agri-chemicals, and specialty chemical sectors.Syngene International Limited was incorporated at Bangalore in the year 1993. During the year 1994-1995, the company pioneered in CRO services for both Chemistry and Biology. During the year 2001-2002, the company acquired a new facility inclusive of a cGMP pilot plant. In March 30, 2002, the companys 99.9% equity share was transferred to Biocon and the... Read More


Reports by Syngene International Ltd


Reports by Syngene International Ltd